The BIRD-2 sensitivity of CLL cells did not correlate to their BCR mutational status, suggesting that basal IP3 signaling might be increased in B-cell cancers irrespective of their BCR mutational status (Supplemental Table 1). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.